XM does not provide services to residents of the United States of America.

A
A

AholdDelhaize

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Reuters - 1 week ago

Antofagasta, Ashtead Group, Close Brothers Group

EUROPE RESEARCH ROUNDUP-Antofagasta, Ashtead Group, Close Brothers Group Dec 1 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Antofagasta, Ashtead Group, and Close Brothers Group, on Friday. HIGHLIGHTS * Antofagasta ANTO.L : Jefferies cuts to hold from buy * Ashtead Group AHT.L : HSBC cuts target price to 5430p from 6860p * Close Brothers Group PLC CBRO.L : Peel Hunt cuts PT to 785p from 832p * LVMH LVMH.PA : Morgan Stanley cuts t
A
A
B
B
C
C
C
C
C
E
E
E
E
G
H
I
K
K
L
M
P
P
R
S
S
T
U
A
A
A
Reuters - 2 weeks ago

Entain, Fresenius Medical Care, Indivior

EUROPE RESEARCH ROUNDUP-Entain, Fresenius Medical Care, Indivior Nov 24 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Entain, Fresenius Medical Care, and Indivior on Friday. HIGHLIGHTS * Endesa ELE.MC : Exane BNP Paribas cuts to neutral from outperform * Entain ENT.L : HSBC cuts target price to 1280p from 1520p * Ferrari N.V.
B
B
B
B
C
D
E
F
F
F
G
I
N
A
A
F
F
Reuters - 2 weeks ago

Largest Dutch online store Bol.com says it will stop advertising on X - ANP

BRIEF-Largest Dutch online store Bol.com says it will stop advertising on X - ANP Nov 23 (Reuters) - Koninklijke Ahold Delhaize NV AD.AS : LARGEST DUTCH ONLINE STORE BOL.COM, OWNED BY AHOLD DELHAIZE, SAYS IT WILL STOP ADVERTISING ON X -ANP Source text for Eikon: [ID:] Further company coverage: AD.AS (Amsterdam Newsroom)
A
Reuters - 3 weeks ago

Ashtead Group, Bayer, Diploma Plc

EUROPE RESEARCH ROUNDUP- Ashtead Group, Bayer, Diploma Plc Nov 21 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Ashtead Group, Bayer AG, and Diploma Plc, on Tuesday. HIGHLIGHTS * Ashtead Group AHT.L : Barclays cuts target price to 6000p from 6300p * Bayer AG BAYGn.DE : Barclays cuts to equal-weight from overweight * Diploma Plc DPLM.L : Peel Hunt raises target price to 3,600p from 3,450p * Intermediate Capital Group Plc ICP.L : J
A
A
B
B
B
C
C
D
D
E
E
H
H
I
M
N
R
S
S
V
V
A
B
B
B
D
I
J
Reuters - 3 weeks ago

MS cuts Ahold Delhaize on lack of catalysts

BUZZ-MS cuts Ahold Delhaize on lack of catalysts ** Morgan Stanley cuts Ahold Delhaize AD.AS from "overweight" to "equal weight" citing lack of catalysts and a downside EPS risk in the U.S. ** "We were conscious of downside EPS risk to come out of the US, however we were hoping for a stronger guide on cost savings and ability to mitigate pressures,
A

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.